Aurinia Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUPH and other ETFs, options, and stocks.About AUPH
Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.
AUPH Key Statistics
Stock Snapshot
As of today, Aurinia Pharmaceuticals(AUPH) shares are valued at $14.11. The company's market cap stands at 1.91B, with a P/E ratio of 6.94.
On 2026-03-26, Aurinia Pharmaceuticals(AUPH) stock opened at $14.53, reached a high of —, and a low of —.
The Aurinia Pharmaceuticals(AUPH)'s current trading volume is 265, compared to an average daily volume of 1.16M.
During the past year, Aurinia Pharmaceuticals(AUPH) stock moved between $6.83 at its lowest and $16.54 at its peak.
During the past year, Aurinia Pharmaceuticals(AUPH) stock moved between $6.83 at its lowest and $16.54 at its peak.
AUPH News
Technology Mutiny At Aurinia Pharmaceuticals? Biotech Soars On C-Suite Shake-Up. Licensing Aurinia Pharmaceuticals (AUPH) announced a complete overhaul of its C...
An update from Aurinia Pharmaceuticals ( (AUPH) ) is now available. Aurinia Pharmaceuticals Inc. announced a leadership change with Board Chair Kevin Tang succ...
Aurinia Pharmaceuticals (AUPH) announced that Kevin Tang, Aurinia’s Chair of the Board, will succeed Peter Greenleaf as Chief Executive Officer. Peter will cont...
Analyst ratings
57%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.